EUVIMEDEUVIMED entdecken
EvaluationsstudieOpen Access

Psychometric evaluation of clinician‐ and caregiver‐reported clinical severity assessments for individuals with CDKL5 deficiency disorder

Jacinta M Saldaris iD, Peter Jacoby iD, Jenny Downs iD, Eric D Marsh iD, Helen Leonard iD, Elia Pestana-Knight iD, Rajsekar Rajaraman iD, Judith Weisenberg iD, Bernhard Suter iD, Heather E Olson iD, Dana Price iD, William Hong iD und 3 weitere

Epilepsia · 2024

DOI: 10.1111/epi.18094 ↗

Kurz gefasst

Evaluationsstudie in der Zeitschrift Epilepsia, 2024. Verfasst von Jacinta M Saldaris und 14 weiteren Autor:innen. Beteiligte Einrichtung: Telethon Kids Institute, Centre for Child Health Research, The University of Western Australia, Perth, Western Australia, Australia. Hauptthemen laut MEDLINE: Caregivers, Epileptic Syndromes, Physicians, Psychometrics. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NICHD NIH HHS, NINDS NIH HHS, International Foundation for CDKL5 Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

The CDKL5 Clinical Severity Assessment (CCSA) is a comprehensive, content‐validated measurement tool capturing the diverse challenges of cyclin‐dependent kinase‐like 5 (CDKL5) deficiency disorder (CDD), a genetically caused developmental epileptic encephalopathy (DEE). The CCSA is divided into clinician‐reported (CCSA‐Clinician) and caregiver‐reported (CCSA‐Caregiver) assessments. The aim of this study was to evaluate the factor structure of these measures through confirmatory factor analysis (CFA) and evaluate their validity and reliability.

Methods

Participants were recruited from the International CDKL5 Clinical Research Network to take part in an in‐clinic CCSA‐Clinician evaluation ( n = 148) and/or complete the CCSA‐Caregiver questionnaire ( n = 198). CFA was used to determine domains, and factor loadings and validity were assessed. For the CCSA‐Clinician, inter‐rater reliability was assessed by nine CDD experienced clinicians via 14 pre‐recorded evaluations. Eight clinicians re‐viewed and re‐scored the videos after 4 weeks to evaluate intra‐rater reliability. The CCSA‐Caregiver was completed on a second occasion by 34 caregivers after 2–4 weeks to assess test–retest reliability.

Results

CFA resulted in three domains for the CCSA‐Clinician (motor and movement, communication, vision) and four domains for the CCSA‐Caregiver (seizures, behavior, alertness, feeding), with good item loadings across both measures. Structural statistics, internal consistency, discriminant validity, and reliability were satisfactory for both measures, and scores were consistent between known groups. Significance This study provides strong evidence that the CCSA measures are suitable to assess the clinical severity of individuals with CDD, supporting their use in clinical trials. Further evaluation of responsiveness to change in a longitudinal assessment is planned. Use may also be appropriate in similar DEEs but would require validation in those populations.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CaregiversEpileptic SyndromesPhysiciansPsychometricsSpasms, InfantileAdolescentChildChild, PreschoolFemaleHumansInfantInfant, NewbornMaleChild BehaviorReproducibility of ResultsSeverity of Illness IndexSurveys and Questionnaires

Stichwörter der Autor:innen

clinical outcome assessmentconfirmatory factor analysisdevelopmental epileptic encephalopathyreliabilityvalidity

Autor:innen und Institutionen

  • Telethon Kids Institute, Centre for Child Health Research, The University of Western Australia, Perth, Western Australia, Australia.
  • Curtin School of Allied Health, Curtin University, Perth, Western Australia, Australia.
  • Departments of Neurology and Pediatrics, Division of Child Neurology and University of Pennsylvania Perelman School of Medicine, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
  • Cleveland Clinic, Neurological Institute, Cleveland, Ohio, USA.
  • UCLA Mattel Children's Hospital, Los Angeles, California, USA.
  • St. Louis Children's Hospital and Washington University School of Medicine, St. Louis, Missouri, USA.

ORCID-Profile: Jacinta M Saldaris, Peter Jacoby, Jenny Downs, Eric D Marsh, Helen Leonard, Elia Pestana-Knight, Rajsekar Rajaraman, Judith Weisenberg, Bernhard Suter, Heather E Olson, Dana Price, William Hong, Erin Prange, Tim A Benke, Scott Demarest

Förderung

  • NICHD NIH HHS
  • NINDS NIH HHS
  • International Foundation for CDKL5 Research
  • National Institutes of Health (NIH)

Zitieren

APA

Saldaris, J. M., Jacoby, P., Downs, J., Marsh, E. D., Leonard, H., Pestana-Knight, E., Rajaraman, R., Weisenberg, J., Suter, B., Olson, H. E., Price, D., Hong, W., Prange, E., Benke, T. A., & Demarest, S. (2024). Psychometric evaluation of clinician‐ and caregiver‐reported clinical severity assessments for individuals with CDKL5 deficiency disorder. Epilepsia. https://doi.org/10.1111/epi.18094

Vancouver

Saldaris JM, Jacoby P, Downs J, Marsh ED, Leonard H, Pestana-Knight E, et al. Psychometric evaluation of clinician‐ and caregiver‐reported clinical severity assessments for individuals with CDKL5 deficiency disorder. Epilepsia. 2024. doi:10.1111/epi.18094

BibTeX
@article{Saldaris2024,
  author = {Saldaris, Jacinta M and Jacoby, Peter and Downs, Jenny and Marsh, Eric D and Leonard, Helen and Pestana-Knight, Elia and Rajaraman, Rajsekar and Weisenberg, Judith and Suter, Bernhard and Olson, Heather E and Price, Dana and Hong, William and Prange, Erin and Benke, Tim A and Demarest, Scott},
  title = {Psychometric evaluation of clinician‐ and caregiver‐reported clinical severity assessments for individuals with CDKL5 deficiency disorder},
  journal = {Epilepsia},
  year = {2024},
  doi = {10.1111/epi.18094}
}
Kostenlos starten →